A Neurofeedback Interface in Poststroke Neuromodulation Using TMS-fNIRS
Recruiting
N/A
Interventional Study
Stroke
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 20 (estimated)
- Sponsor
- The Hong Kong Polytechnic University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Stroke is a type of cerebrovascular disease, and the primary characteristic of post-stroke brains is pathological changes in cerebral hemodynamics. Therefore, hemodynamic signals may provide straightforward information for guiding post-stroke neuromodulation therapy. Transcranial magnetic stimulation (TMS), a non-invasive neurostimulation modality, has been extensively used in post-stroke rehabili…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Participants who meet the following criteria will be included:
1. Diagnosed with ischemic subcortical stroke, with stroke onset≥6 months.
2. Age between 18 and 80 years.
3. Residual upper limb functions between levels 2-7 in the FTHUE.
4. Capable of providing informed written c…
Contacts